Identification of novel inhibitors of rat Mrp3.

[1]  M. Vinken,et al.  Current insights in the complexities underlying drug-induced cholestasis , 2019, Critical reviews in toxicology.

[2]  P. Annaert,et al.  MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study , 2018, Drug Metabolism and Disposition.

[3]  B. Stieger,et al.  Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine , 2017, Pharmaceutical Research.

[4]  S. Mandlekar,et al.  Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay , 2017, Drug Metabolism and Disposition.

[5]  K. Brouwer,et al.  Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Jie Liu,et al.  Ontogeny, aging, and gender‐related changes in hepatic multidrug resistant protein genes in rats , 2017, Life sciences.

[7]  M. Parvez,et al.  Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake , 2016, Antimicrobial Agents and Chemotherapy.

[8]  P. Annaert,et al.  Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes , 2016, Drug Metabolism and Disposition.

[9]  M. Iwaki,et al.  Stereoselective Inhibition of Methotrexate Excretion by Glucuronides of Nonsteroidal Anti-inflammatory Drugs via Multidrug Resistance Proteins 2 and 4 , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[10]  P. Herdewijn,et al.  In vitro disposition profiling of heterocyclic compounds. , 2015, International journal of pharmaceutics.

[11]  Olivier Fardel,et al.  Nature and uses of fluorescent dyes for drug transporter studies , 2015, Expert opinion on drug metabolism & toxicology.

[12]  J. Manautou,et al.  Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac , 2015, Drug Metabolism and Disposition.

[13]  Zhe-Sheng Chen,et al.  Multidrug Resistance Proteins (MRPs) and Cancer Therapy , 2015, The AAPS Journal.

[14]  K. Maeda.  Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs. , 2015, Biological & pharmaceutical bulletin.

[15]  Sanjay K. Nigam,et al.  What do drug transporters really do? , 2014, Nature Reviews Drug Discovery.

[16]  J. Markowitz,et al.  Enzyme- and transporter-mediated drug interactions with small molecule tyrosine kinase inhibitors. , 2014, Journal of pharmaceutical sciences.

[17]  R. Weaver,et al.  Quantification of biliary excretion and sinusoidal excretion of 5(6)-carboxy-2',7'-dichlorofluorescein (CDF) in cultured hepatocytes isolated from Sprague Dawley, Wistar and Mrp2-deficient Wistar (TR(-)) rats. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  A. D. Rodrigues,et al.  Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump , 2014, Drug Metabolism and Disposition.

[19]  S. Ekins,et al.  Human Immunodeficiency Virus Protease Inhibitors Interact with ATP Binding Cassette Transporter 4/Multidrug Resistance Protein 4: A Basis for Unanticipated Enhanced Cytotoxicity , 2013, Molecular Pharmacology.

[20]  K. Brouwer,et al.  In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development , 2013, Clinical pharmacology and therapeutics.

[21]  G. V. van Westen,et al.  Structure-Based Identification of OATP1B1/3 Inhibitors , 2013, Molecular Pharmacology.

[22]  K. Brouwer,et al.  A Perspective on Efflux Transport Proteins in the Liver , 2012, Clinical pharmacology and therapeutics.

[23]  T. Horie,et al.  Interaction of Mrp2 with radixin causes reversible canalicular Mrp2 localization induced by intracellular redox status. , 2011, Biochimica et biophysica acta.

[24]  J. Sahi,et al.  Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  K. Jemnitz,et al.  ABCC2/Abcc2: a multispecific transporter with dominant excretory functions , 2010, Drug metabolism reviews.

[26]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[27]  M. Niemi,et al.  Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.

[28]  K. Maeda,et al.  Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine , 2008, Molecular Pharmacology.

[29]  E. Kis,et al.  Characterization of 5(6)-Carboxy-2,′7′-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4 , 2008, Journal of biomolecular screening.

[30]  K. Brouwer,et al.  Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes , 2008, Drug Metabolism and Disposition.

[31]  Mei-Hwei Chang,et al.  Developmental expression of canalicular transporter genes in human liver , 2005 .

[32]  K. Brouwer,et al.  Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.

[33]  K. Brouwer,et al.  P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[34]  H. Takikawa,et al.  ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)* , 2000, The Journal of Biological Chemistry.

[35]  G. Peters,et al.  MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .

[37]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[38]  H. Galla,et al.  Substrate translocation and stimulated ATP hydrolysis of human ABC transporter MRP3 show positive cooperativity and are half-coupled. , 2013, Biophysical chemistry.